6-108323845-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145315.5(AFG1L):c.160G>A(p.Glu54Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,613,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145315.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFG1L | NM_145315.5 | c.160G>A | p.Glu54Lys | missense_variant | 2/13 | ENST00000368977.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFG1L | ENST00000368977.9 | c.160G>A | p.Glu54Lys | missense_variant | 2/13 | 1 | NM_145315.5 | P1 | |
AFG1L | ENST00000437715.1 | c.61G>A | p.Glu21Lys | missense_variant | 3/6 | 5 | |||
AFG1L | ENST00000421954.5 | c.18+28627G>A | intron_variant | 5 | |||||
AFG1L | ENST00000430458.1 | n.249G>A | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251440Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135894
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727200
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.160G>A (p.E54K) alteration is located in exon 2 (coding exon 2) of the LACE1 gene. This alteration results from a G to A substitution at nucleotide position 160, causing the glutamic acid (E) at amino acid position 54 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at